ZDBF2/SIRT6-mediated H3K27 deacetylation inhibits ferroptosis and reduces sensitivity of oral squamous cell carcinoma to cisplatin.

Liu K, Rong L, Shuai Y, Mu R, Ding H, Chen B, Jin L.

Open source

DOI
10.1016/j.prp.2026.156419
Published
2026-02-24
Container
Pathol Res Pract
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.prp.2026.156419,
  title = {ZDBF2/SIRT6-mediated H3K27 deacetylation inhibits ferroptosis and reduces sensitivity of oral squamous cell carcinoma to cisplatin.},
  author = {Liu K and  Rong L and  Shuai Y and  Mu R and  Ding H and  Chen B and  Jin L.},
  year = {2026},
  journal = {Pathol Res Pract},
  doi = {10.1016/j.prp.2026.156419},
  url = {https://doi.org/10.1016/j.prp.2026.156419}
}

RIS

TY  - JOUR
TI  - ZDBF2/SIRT6-mediated H3K27 deacetylation inhibits ferroptosis and reduces sensitivity of oral squamous cell carcinoma to cisplatin.
AU  - Liu K
AU  -  Rong L
AU  -  Shuai Y
AU  -  Mu R
AU  -  Ding H
AU  -  Chen B
AU  -  Jin L.
PY  - 2026
JO  - Pathol Res Pract
DO  - 10.1016/j.prp.2026.156419
UR  - https://doi.org/10.1016/j.prp.2026.156419
ER  - 

APA

K, L., L, R., Y, S., R, M., H, D., B, C., & L., J. (2026). ZDBF2/SIRT6-mediated H3K27 deacetylation inhibits ferroptosis and reduces sensitivity of oral squamous cell carcinoma to cisplatin.. Pathol Res Pract. https://doi.org/10.1016/j.prp.2026.156419

Source records